Mirtazapine in Comorbid Major Depression and Alcohol Dependence: An Open-Label Trial
- 1 July 2012
- journal article
- research article
- Published by Taylor & Francis in Journal of Dual Diagnosis
- Vol. 8 (3) , 200-204
Abstract
Objective: This was a first pilot study evaluating the acute phase (8-week) efficacy of the antidepressant medication mirtazapine for the treatment of depressive symptoms and drinking of subjects with comorbid major depressive disorder and alcohol dependence (MDD/AD). We hypothesized that mirtazapine would demonstrate within-group efficacy for the treatment of both depressive symptoms and drinking in these subjects. Methods: We conducted a first open-label study of the second-generation antidepressant mirtazapine in 12 adult outpatient subjects with comorbid MDD/AD. The pharmacological profile of that medication is unique among antidepressants, unrelated to tricyclics or selective serotonin reuptake inhibitors. Results: Mirtazapine was well tolerated in this treatment population. Self-reported depressive symptoms decreased from 31.8 to 8.3 on the Beck Depression Inventory (BDI), a 74.0% decrease (p < .001), and drinking decreased from 33.9 to 13.3 drinks per week, a 60.8% decrease (p < .05). None of the subjects were employed full time at baseline, but 9 of the 12 (75%) were employed full time at the end the of study. Conclusions: These preliminary findings suggest efficacy for mirtazapine for treating both the depressive symptoms and excessive alcohol use of comorbid major depressive disorder and alcohol dependence. Double-blind studies are warranted to further clarify the efficacy of mirtazapine in this population.Keywords
This publication has 11 references indexed in Scilit:
- Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use DisordersThe Journal of Clinical Psychiatry, 2011
- Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorderAddictive Behaviors, 2009
- Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysisThe Lancet, 2009
- Mirtazapine Versus Other Antidepressants in the Acute-Phase Treatment of Adults With Major DepressionThe Journal of Clinical Psychiatry, 2008
- Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co‐morbid depressive disorder: a randomized, double‐blind studyHuman Psychopharmacology: Clinical and Experimental, 2008
- Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: A multicentre, open label studyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2006
- Treatment of Depression in Patients With Alcohol or Other Drug DependenceJAMA, 2004
- The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.1998
- Reliability of a Timeline Method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populationsBritish Journal of Addiction, 1988
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961